Chemistry:Mericitabine

From HandWiki
Short description: Chemical compound
Mericitabine
Mericitabine structure.png
Clinical data
Trade namesMericitabine
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC18H26FN3O6
Molar mass399.419 g·mol−1
3D model (JSmol)

Mericitabine (RG-7128) is an antiviral drug, a deoxycytidine analog (a type of nucleoside analog). It was developed as a treatment for hepatitis C, acting as a NS5B RNA polymerase inhibitor, but while it showed a good safety profile in clinical trials, it was not sufficiently effective to be used as a stand-alone agent. However mericitabine has been shown to boost the efficacy of other antiviral drugs when used alongside them, and as most modern treatment regimens for hepatitis C use a combination therapy of several antiviral drugs, clinical trials have continued to see if it can form a part of a clinically useful drug treatment program.[1][2]

See also

References

  1. "Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus". Expert Opinion on Investigational Drugs 23 (9): 1211–23. September 2014. doi:10.1517/13543784.2014.921680. PMID 24848437. 
  2. "Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies". PLOS ONE 11 (1): e0145409. 2016. doi:10.1371/journal.pone.0145409. PMID 26752189. Bibcode2016PLoSO..1145409W.